PubMed:1351090 JSONTXT

{"project":"jnlpba-st-training","denotations":[{"id":"T1","span":{"begin":45,"end":89},"obj":"cell_line"},{"id":"T2","span":{"begin":126,"end":142},"obj":"protein"},{"id":"T3","span":{"begin":216,"end":229},"obj":"cell_line"},{"id":"T4","span":{"begin":243,"end":256},"obj":"protein"},{"id":"T5","span":{"begin":274,"end":279},"obj":"protein"},{"id":"T6","span":{"begin":410,"end":426},"obj":"protein"},{"id":"T7","span":{"begin":428,"end":431},"obj":"protein"},{"id":"T8","span":{"begin":470,"end":500},"obj":"protein"},{"id":"T9","span":{"begin":535,"end":575},"obj":"cell_line"},{"id":"T10","span":{"begin":624,"end":627},"obj":"protein"},{"id":"T11","span":{"begin":668,"end":671},"obj":"protein"},{"id":"T12","span":{"begin":746,"end":749},"obj":"protein"},{"id":"T13","span":{"begin":812,"end":824},"obj":"protein"},{"id":"T14","span":{"begin":843,"end":869},"obj":"DNA"},{"id":"T15","span":{"begin":894,"end":939},"obj":"DNA"},{"id":"T16","span":{"begin":981,"end":986},"obj":"protein"},{"id":"T17","span":{"begin":1025,"end":1059},"obj":"protein"},{"id":"T18","span":{"begin":1061,"end":1064},"obj":"protein"},{"id":"T19","span":{"begin":1083,"end":1129},"obj":"DNA"},{"id":"T20","span":{"begin":1157,"end":1160},"obj":"protein"},{"id":"T21","span":{"begin":1267,"end":1288},"obj":"protein"},{"id":"T22","span":{"begin":1401,"end":1406},"obj":"protein"},{"id":"T23","span":{"begin":1439,"end":1456},"obj":"cell_type"},{"id":"T24","span":{"begin":1500,"end":1530},"obj":"protein"},{"id":"T25","span":{"begin":1568,"end":1581},"obj":"protein"},{"id":"T26","span":{"begin":1696,"end":1718},"obj":"protein"},{"id":"T27","span":{"begin":1773,"end":1776},"obj":"protein"},{"id":"T28","span":{"begin":1793,"end":1798},"obj":"protein"}],"text":"Reduced susceptibility to HIV-1 infection of ethyl-methanesulfonate-treated CEM subclones correlates with a blockade in their protein kinase C signaling pathway.\nWe have described the isolation of chemically induced CEM subclones that express CD4 receptors and bind soluble gp120, yet show a markedly reduced susceptibility to infection with HIV-1. Two subclones were found to have an abnormal response to the protein kinase C (PKC) activator PMA. PMA treatment induced CD3 and CD25 (IL-2R) receptors on the parental line and on other ethyl-methanesulfonate-derived subclones, but not on these two mutants. Direct assays of PKC activity were conducted. Total cellular PKC enzymatic activity was found to be normal in these subclones. PMA-induced CD4 down-modulation occurred normally. In addition, activation of c-raf kinase was normal. Since HIV-1 long terminal repeat contains two functional nuclear factor kB (NF-kB) regulatory elements, we studied the ability of PMA to induce NF-kB binding activity by different assays. Chloramphenicol acetyl transferase (CAT) assays using the HIV-1 (-139)long terminal repeat-CAT construct showed no PMA induction of CAT activity in these subclones (unlike the parental line and other subclones). Okadaic acid, an inhibitor of phosphatases 1 and 2A, did not overcome the defect in these subclones. Gel retardation assays, using a 32P-probe containing the HIV-1 NF-kB probe and nuclear extracts from PMA-treated cells, showed significantly reduced induction of nuclear NF-kB binding proteins in these two subclones compared with wild type CEM and a control subclone. Deoxycholate treatment of cytoplasmic extracts from these subclones released much reduced NF-kB binding proteins from their cytoplasmic pools. Thus, reduced levels of PKC-induced nuclear NF-kB activity in two T cell subclones did not affect their normal cell growth, but correlated with a pronounced reduction in their susceptibility to HIV-1 infection."}

{"project":"pubmed-sentences-benchmark","denotations":[{"id":"S1","span":{"begin":0,"end":161},"obj":"Sentence"},{"id":"S2","span":{"begin":162,"end":348},"obj":"Sentence"},{"id":"S3","span":{"begin":349,"end":447},"obj":"Sentence"},{"id":"S4","span":{"begin":448,"end":606},"obj":"Sentence"},{"id":"S5","span":{"begin":607,"end":652},"obj":"Sentence"},{"id":"S6","span":{"begin":653,"end":733},"obj":"Sentence"},{"id":"S7","span":{"begin":734,"end":784},"obj":"Sentence"},{"id":"S8","span":{"begin":785,"end":836},"obj":"Sentence"},{"id":"S9","span":{"begin":837,"end":1024},"obj":"Sentence"},{"id":"S10","span":{"begin":1025,"end":1236},"obj":"Sentence"},{"id":"S11","span":{"begin":1237,"end":1337},"obj":"Sentence"},{"id":"S12","span":{"begin":1338,"end":1605},"obj":"Sentence"},{"id":"S13","span":{"begin":1606,"end":1748},"obj":"Sentence"},{"id":"S14","span":{"begin":1749,"end":1959},"obj":"Sentence"}],"text":"Reduced susceptibility to HIV-1 infection of ethyl-methanesulfonate-treated CEM subclones correlates with a blockade in their protein kinase C signaling pathway.\nWe have described the isolation of chemically induced CEM subclones that express CD4 receptors and bind soluble gp120, yet show a markedly reduced susceptibility to infection with HIV-1. Two subclones were found to have an abnormal response to the protein kinase C (PKC) activator PMA. PMA treatment induced CD3 and CD25 (IL-2R) receptors on the parental line and on other ethyl-methanesulfonate-derived subclones, but not on these two mutants. Direct assays of PKC activity were conducted. Total cellular PKC enzymatic activity was found to be normal in these subclones. PMA-induced CD4 down-modulation occurred normally. In addition, activation of c-raf kinase was normal. Since HIV-1 long terminal repeat contains two functional nuclear factor kB (NF-kB) regulatory elements, we studied the ability of PMA to induce NF-kB binding activity by different assays. Chloramphenicol acetyl transferase (CAT) assays using the HIV-1 (-139)long terminal repeat-CAT construct showed no PMA induction of CAT activity in these subclones (unlike the parental line and other subclones). Okadaic acid, an inhibitor of phosphatases 1 and 2A, did not overcome the defect in these subclones. Gel retardation assays, using a 32P-probe containing the HIV-1 NF-kB probe and nuclear extracts from PMA-treated cells, showed significantly reduced induction of nuclear NF-kB binding proteins in these two subclones compared with wild type CEM and a control subclone. Deoxycholate treatment of cytoplasmic extracts from these subclones released much reduced NF-kB binding proteins from their cytoplasmic pools. Thus, reduced levels of PKC-induced nuclear NF-kB activity in two T cell subclones did not affect their normal cell growth, but correlated with a pronounced reduction in their susceptibility to HIV-1 infection."}

{"project":"genia-medco-coref","denotations":[{"id":"C1","span":{"begin":0,"end":41},"obj":"NP"},{"id":"C2","span":{"begin":45,"end":89},"obj":"NP"},{"id":"C3","span":{"begin":120,"end":125},"obj":"NP"},{"id":"C4","span":{"begin":197,"end":229},"obj":"NP"},{"id":"C5","span":{"begin":230,"end":234},"obj":"NP"},{"id":"C6","span":{"begin":290,"end":347},"obj":"NP"},{"id":"C7","span":{"begin":349,"end":362},"obj":"NP"},{"id":"C8","span":{"begin":406,"end":446},"obj":"NP"},{"id":"C9","span":{"begin":448,"end":451},"obj":"NP"},{"id":"C10","span":{"begin":504,"end":521},"obj":"NP"},{"id":"C11","span":{"begin":529,"end":575},"obj":"NP"},{"id":"C12","span":{"begin":588,"end":605},"obj":"NP"},{"id":"C13","span":{"begin":717,"end":732},"obj":"NP"},{"id":"C14","span":{"begin":967,"end":970},"obj":"NP"},{"id":"C15","span":{"begin":1025,"end":1065},"obj":"NP"},{"id":"C16","span":{"begin":1140,"end":1143},"obj":"NP"},{"id":"C17","span":{"begin":1157,"end":1160},"obj":"NP"},{"id":"C18","span":{"begin":1173,"end":1188},"obj":"NP"},{"id":"C19","span":{"begin":1197,"end":1214},"obj":"NP"},{"id":"C20","span":{"begin":1219,"end":1234},"obj":"NP"},{"id":"C21","span":{"begin":1237,"end":1249},"obj":"NP"},{"id":"C22","span":{"begin":1251,"end":1288},"obj":"NP"},{"id":"C23","span":{"begin":1321,"end":1336},"obj":"NP"},{"id":"C24","span":{"begin":1500,"end":1530},"obj":"NP"},{"id":"C25","span":{"begin":1534,"end":1553},"obj":"NP"},{"id":"C26","span":{"begin":1658,"end":1673},"obj":"NP"},{"id":"C27","span":{"begin":1683,"end":1718},"obj":"NP"},{"id":"C28","span":{"begin":1724,"end":1729},"obj":"NP"},{"id":"C29","span":{"begin":1811,"end":1831},"obj":"NP"},{"id":"C30","span":{"begin":1847,"end":1852},"obj":"NP"},{"id":"C32","span":{"begin":1919,"end":1924},"obj":"NP"},{"id":"C31","span":{"begin":1919,"end":1958},"obj":"NP"}],"relations":[{"id":"R1","pred":"coref-pron","subj":"C3","obj":"C2"},{"id":"R2","pred":"coref-relat","subj":"C5","obj":"C4"},{"id":"R3","pred":"coref-ident","subj":"C6","obj":"C1"},{"id":"R4","pred":"coref-other","subj":"C7","obj":"C4"},{"id":"R5","pred":"coref-ident","subj":"C9","obj":"C8"},{"id":"R6","pred":"coref-ident","subj":"C12","obj":"C7"},{"id":"R7","pred":"coref-ident","subj":"C13","obj":"C12"},{"id":"R8","pred":"coref-ident","subj":"C14","obj":"C9"},{"id":"R9","pred":"coref-ident","subj":"C16","obj":"C14"},{"id":"R10","pred":"coref-ident","subj":"C17","obj":"C15"},{"id":"R11","pred":"coref-ident","subj":"C18","obj":"C13"},{"id":"R12","pred":"coref-ident","subj":"C19","obj":"C10"},{"id":"R13","pred":"coref-ident","subj":"C20","obj":"C11"},{"id":"R14","pred":"coref-appos","subj":"C22","obj":"C21"},{"id":"R15","pred":"coref-ident","subj":"C23","obj":"C18"},{"id":"R16","pred":"coref-ident","subj":"C25","obj":"C23"},{"id":"R17","pred":"coref-ident","subj":"C26","obj":"C25"},{"id":"R18","pred":"coref-other","subj":"C27","obj":"C24"},{"id":"R19","pred":"coref-pron","subj":"C28","obj":"C26"},{"id":"R20","pred":"coref-other","subj":"C29","obj":"C26"},{"id":"R21","pred":"coref-pron","subj":"C30","obj":"C29"},{"id":"R22","pred":"coref-pron","subj":"C32","obj":"C29"},{"id":"R23","pred":"coref-other","subj":"C31","obj":"C6"}],"text":"Reduced susceptibility to HIV-1 infection of ethyl-methanesulfonate-treated CEM subclones correlates with a blockade in their protein kinase C signaling pathway.\nWe have described the isolation of chemically induced CEM subclones that express CD4 receptors and bind soluble gp120, yet show a markedly reduced susceptibility to infection with HIV-1. Two subclones were found to have an abnormal response to the protein kinase C (PKC) activator PMA. PMA treatment induced CD3 and CD25 (IL-2R) receptors on the parental line and on other ethyl-methanesulfonate-derived subclones, but not on these two mutants. Direct assays of PKC activity were conducted. Total cellular PKC enzymatic activity was found to be normal in these subclones. PMA-induced CD4 down-modulation occurred normally. In addition, activation of c-raf kinase was normal. Since HIV-1 long terminal repeat contains two functional nuclear factor kB (NF-kB) regulatory elements, we studied the ability of PMA to induce NF-kB binding activity by different assays. Chloramphenicol acetyl transferase (CAT) assays using the HIV-1 (-139)long terminal repeat-CAT construct showed no PMA induction of CAT activity in these subclones (unlike the parental line and other subclones). Okadaic acid, an inhibitor of phosphatases 1 and 2A, did not overcome the defect in these subclones. Gel retardation assays, using a 32P-probe containing the HIV-1 NF-kB probe and nuclear extracts from PMA-treated cells, showed significantly reduced induction of nuclear NF-kB binding proteins in these two subclones compared with wild type CEM and a control subclone. Deoxycholate treatment of cytoplasmic extracts from these subclones released much reduced NF-kB binding proteins from their cytoplasmic pools. Thus, reduced levels of PKC-induced nuclear NF-kB activity in two T cell subclones did not affect their normal cell growth, but correlated with a pronounced reduction in their susceptibility to HIV-1 infection."}

{"project":"GENIAcorpus","denotations":[{"id":"T1","span":{"begin":26,"end":31},"obj":"virus"},{"id":"T2","span":{"begin":45,"end":89},"obj":"cell_line"},{"id":"T3","span":{"begin":126,"end":142},"obj":"protein_molecule"},{"id":"T4","span":{"begin":216,"end":229},"obj":"cell_line"},{"id":"T5","span":{"begin":243,"end":256},"obj":"protein_family_or_group"},{"id":"T6","span":{"begin":274,"end":279},"obj":"protein_molecule"},{"id":"T7","span":{"begin":342,"end":347},"obj":"virus"},{"id":"T8","span":{"begin":410,"end":426},"obj":"protein_molecule"},{"id":"T9","span":{"begin":428,"end":431},"obj":"protein_molecule"},{"id":"T10","span":{"begin":443,"end":446},"obj":"other_organic_compound"},{"id":"T11","span":{"begin":448,"end":461},"obj":"other_name"},{"id":"T12","span":{"begin":535,"end":575},"obj":"cell_line"},{"id":"T13","span":{"begin":624,"end":627},"obj":"protein_molecule"},{"id":"T14","span":{"begin":668,"end":671},"obj":"protein_molecule"},{"id":"T15","span":{"begin":734,"end":737},"obj":"other_organic_compound"},{"id":"T16","span":{"begin":746,"end":749},"obj":"protein_molecule"},{"id":"T17","span":{"begin":812,"end":824},"obj":"protein_molecule"},{"id":"T18","span":{"begin":843,"end":869},"obj":"DNA_domain_or_region"},{"id":"T19","span":{"begin":894,"end":913},"obj":"DNA_domain_or_region"},{"id":"T20","span":{"begin":913,"end":918},"obj":"protein_molecule"},{"id":"T21","span":{"begin":967,"end":970},"obj":"other_organic_compound"},{"id":"T22","span":{"begin":981,"end":986},"obj":"protein_molecule"},{"id":"T23","span":{"begin":1025,"end":1059},"obj":"protein_molecule"},{"id":"T24","span":{"begin":1061,"end":1064},"obj":"protein_molecule"},{"id":"T25","span":{"begin":1083,"end":1088},"obj":"virus"},{"id":"T26","span":{"begin":1140,"end":1143},"obj":"other_organic_compound"},{"id":"T27","span":{"begin":1157,"end":1160},"obj":"protein_molecule"},{"id":"T28","span":{"begin":1237,"end":1249},"obj":"other_organic_compound"},{"id":"T29","span":{"begin":1338,"end":1360},"obj":"other_name"},{"id":"T30","span":{"begin":1370,"end":1379},"obj":"other_organic_compound"},{"id":"T31","span":{"begin":1395,"end":1400},"obj":"virus"},{"id":"T32","span":{"begin":1401,"end":1406},"obj":"protein_molecule"},{"id":"T33","span":{"begin":1417,"end":1433},"obj":"cell_component"},{"id":"T34","span":{"begin":1439,"end":1442},"obj":"other_organic_compound"},{"id":"T35","span":{"begin":1500,"end":1507},"obj":"protein_family_or_group"},{"id":"T36","span":{"begin":1508,"end":1513},"obj":"protein_molecule"},{"id":"T37","span":{"begin":1568,"end":1577},"obj":"protein_molecule"},{"id":"T38","span":{"begin":1578,"end":1581},"obj":"protein_molecule"},{"id":"T39","span":{"begin":1606,"end":1618},"obj":"other_organic_compound"},{"id":"T40","span":{"begin":1632,"end":1652},"obj":"cell_component"},{"id":"T41","span":{"begin":1696,"end":1701},"obj":"protein_molecule"},{"id":"T42","span":{"begin":1773,"end":1776},"obj":"protein_molecule"},{"id":"T43","span":{"begin":1793,"end":1798},"obj":"protein_molecule"},{"id":"T44","span":{"begin":1943,"end":1948},"obj":"virus"}],"text":"Reduced susceptibility to HIV-1 infection of ethyl-methanesulfonate-treated CEM subclones correlates with a blockade in their protein kinase C signaling pathway.\nWe have described the isolation of chemically induced CEM subclones that express CD4 receptors and bind soluble gp120, yet show a markedly reduced susceptibility to infection with HIV-1. Two subclones were found to have an abnormal response to the protein kinase C (PKC) activator PMA. PMA treatment induced CD3 and CD25 (IL-2R) receptors on the parental line and on other ethyl-methanesulfonate-derived subclones, but not on these two mutants. Direct assays of PKC activity were conducted. Total cellular PKC enzymatic activity was found to be normal in these subclones. PMA-induced CD4 down-modulation occurred normally. In addition, activation of c-raf kinase was normal. Since HIV-1 long terminal repeat contains two functional nuclear factor kB (NF-kB) regulatory elements, we studied the ability of PMA to induce NF-kB binding activity by different assays. Chloramphenicol acetyl transferase (CAT) assays using the HIV-1 (-139)long terminal repeat-CAT construct showed no PMA induction of CAT activity in these subclones (unlike the parental line and other subclones). Okadaic acid, an inhibitor of phosphatases 1 and 2A, did not overcome the defect in these subclones. Gel retardation assays, using a 32P-probe containing the HIV-1 NF-kB probe and nuclear extracts from PMA-treated cells, showed significantly reduced induction of nuclear NF-kB binding proteins in these two subclones compared with wild type CEM and a control subclone. Deoxycholate treatment of cytoplasmic extracts from these subclones released much reduced NF-kB binding proteins from their cytoplasmic pools. Thus, reduced levels of PKC-induced nuclear NF-kB activity in two T cell subclones did not affect their normal cell growth, but correlated with a pronounced reduction in their susceptibility to HIV-1 infection."}